@ozgoldtrader
try this one (end of April 2022)
Financial Position
The Company closed the quarter with total cash of $0.78 million. Inventory on the balance sheet was
$2.6 million, up from $1.4 million in the previous quarter. The increase was required to cater for the
strong sales pipeline based on recent contract wins.
The Company received payments during the quarter of $0.67 million from sales of assistive
technology to enterprise customers.
Total active subscriptions producing recurring revenue increased to more than 12,200 by the end of
the quarter which represents a 12.4% increase from December 2021 and a 95.1% year on year
increase.
- Forums
- ASX - By Stock
- RAP
- Valuing ResApp Health
Valuing ResApp Health, page-212
-
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online